| Primary information |
|---|
| CancerPDF_ID | CancerPDF_ID8702 |
| PMID | 24694173 |
| Peptide Sequence | ALREVQPVELPNCNLV |
| Peptide Sequence in Publication | ALREVQPVELPNCNLV |
| Protein Name | Serum paraoxonase/arylesterase 1 |
| UniprotKB Entry Name | PON1_HUMAN |
| Biofluid | Ascites fluid |
| M/Z | NA |
| Charge | 1 |
| Mass/H+ | NA |
| Mass (in Daltons) | NA |
| Profiling Technique | LTQ-Orbitrap XL |
| Peptide Identification Technique | X tandem for peptide identification |
| Quantification Technique | NA |
| Labeling | Label Free |
| FDR | NA |
| p-Value | NA |
| Software | "X tandem for peptide identification,Scaffold 2 software for any modification analysis" |
| Length of Peptide | 16 |
| Cancer Type | Ovarian cancer |
| Database for Peptide search | IPI00218732 |
| Modification | NA |
| Number of Patients | 3 ovarian cancer patient and 3 non cancerous control |
| Regulation/Differential Expression | Uniquely expressed in ovarian cancer patient |
| Validation | NA |
| Sensitivity | NA |
| Specificity | NA |
| Accuracy | NA |
| Secondary information |
|---|
| Peptide Atlas | NA |
| IEDB | |